COPD

The AJMC® COPD compendium is a comprehensive resource for clinical news and expert insights for chronic obstructive pulmonary disease.

Latest News
November 12th 2024

COPD Mortality Falls in China, Yet High Burden Persists in Underdeveloped Regions

October 30th 2024

Prednisone Superior to Other Corticosteroids for Patients With COPD, Heart Failure

October 28th 2024

NIVO Score Accurately Predicts Mortality, Noninvasive Ventilation Failure in Patients With AECOPD

October 23rd 2024

Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks

October 15th 2024

Ineligibility, Limitations to PR Uptake in Patients With AECOPD

Type 2 Inflammation: A Common Theme Among Several Chronic Diseases

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.

Learn about the multifaceted aspects of type 2 inflammatory diseases, including impact on quality of life; the role of biomarkers in diagnosis and treatment selection; and unmet needs in clinical management.
Video Interviews
View All
November 5th 2024

Exploring the Differential Effectiveness of ICS by Smoking Status in COPD

October 10th 2024

Tailoring COPD Treatments Among Smokers, Nonsmokers

October 1st 2024

Dupilumab Improves Lung Function, Type 2 Inflammation in COPD

June 8th 2024

Dr Surya Bhatt on Dupilumab's Promise in Reducing COPD Exacerbations, Enhancing Quality of Life

June 1st 2024

Dr Surya Bhatt Highlights NOTUS Trial Findings, Promising Dupilumab Results

June 2nd 2023

Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPD

May 22nd 2023

Dr Debra Boyer: Childhood Respiratory Illness Impacts Adult Health

January 18th 2023

Key Takeaways and Considerations Surrounding COPD Therapies

January 18th 2023

Cost Drivers Impacting Treatment Strategies for COPD

January 11th 2023

Role of Non-Medication Strategies in COPD Treatment Pathway

Podcasts
View All
November 16th 2021

A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs

August 26th 2017

Podcast: This Week in Managed Care - When to Start Mammography, and Other Health News

June 3rd 2017

Podcast: This Week in Managed Care - Fighting Medicare Fraud, and Other News

Continuing Medical Education
View All
November 21st 2024

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

More News

Definition of opioids | Image Credit: Feng Yu - stock.adobe.com
September 30th 2024

Opioids, Benzodiazepines Linked to Higher Mortality in Older Patients With COPD

Brooke McCormick
A study found that opioid use, with or without benzodiazepines, significantly increases long-term mortality risk in patients with chronic obstructive pulmonary disease (COPD) over the age of 60 years.
FDA approval stamp | Image Credit: cartoon - stock.adobe.com
September 27th 2024

FDA Approves Dupilumab as First Biologic Treatment for COPD

Brooke McCormick
The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype to significantly help reduce exacerbations and improve lung function.
Man reaching for cigarette | Image Credit: Nopphon - stock.adobe.com
September 26th 2024

COPD Poses Public Health Risk for US Smokers, Nonsmokers

Brooke McCormick
While smoking is a key risk factor for chronic obstructive pulmonary disease (COPD), significant prevalence also exists among nonsmokers, highlighting the need for broader public health strategies.
AJMC
September 18th 2024

COPD Treatment Ratio: A Measure for Improving COPD Population Health

Megha A. Parikh, PhD, MS Sabree C. Burbage, PharmD, MPH Meghan H. Gabriel, PhD Ben E. Shirley, BSPH Patrick J. Campbell, PharmD, PhD
This article supports the use of the chronic obstructive pulmonary disease (COPD) treatment ratio as a surrogate marker of COPD exacerbation risk for quality measurement purposes.
Conversation drawing | Image Credit: Julien Eichinger - stock.adobe.com
September 11th 2024

Social Frailty Indirectly Affects Anxiety, Depression in Patients With AECOPD Through Social Support

Brooke McCormick
Social frailty in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) does not directly impact anxiety or depression but influences these conditions indirectly through social support.
COPD drawing | Image Credit: Ivelin Radkov - stock.adobe.com
September 6th 2024

Roflumilast Linked to Higher 5-Year Mortality in Patients With COPD in US, Germany

Brooke McCormick
A small 5-year all-cause mortality risk increase among patients with chronic obstructive pulmonary disease (COPD) using roflumilast was found in Germany and the US.
COPD animation | Image Credit: peterschreiber.media - stock.adobe.com
August 20th 2024

Study: Most Patients With COPD Remain Untreated Following Initial Diagnosis

Brooke McCormick
Most patients with chronic obstructive pulmonary disease (COPD) remain untreated after diagnosis, leading to frequent exacerbations.
Definition of malnutrition | Image Credit: Feng Yu - stock.adobe.com
August 15th 2024

Malnutrition in Older Patients With COPD Linked to Higher Hospital Readmission Rates

Brooke McCormick
Malnutrition significantly increases the 180-day hospital readmission rates among patients 65 years or older with chronic obstructive pulmonary disease (COPD), highlighting the importance of monitoring and improving their nutritional status.
Female patient using an inhaler | Image Credit: DALU11 - stock.adobe.com
August 10th 2024

Medicare Advantage Program Linked to Higher Inhaler Adherence in Patients With COPD

Brooke McCormick
Medicare Advantage beneficiaries with chronic obstructive pulmonary disease (COPD) who were invited to enroll in a program that reduced inhaler costs and provided medication management had higher inhaler adherence; however, there was no significant impact on exacerbations or overall health care spending.
Man holding an empty wallet | Image Credit: methaphum - stock.adobe.com
August 7th 2024

Poor Socioeconomic Status Linked to Higher COPD Risk in Chinese Adults, Study Finds

Brooke McCormick
Chinese adults with a poor socioeconomic status are at a higher risk of developing chronic obstructive pulmonary disease (COPD).
Patient with psoriasis | Image Credit: Daniel Beckemeier
July 29th 2024

Study: Psoriasis Not an Independent Risk Factor for COPD Development

Brooke McCormick
Psoriasis is not an independent risk factor for developing chronic obstructive pulmonary disease (COPD), according to a new study.
Female patient receiving care from general practitioner | Image Credit: bongkarn - stock.adobe.com
July 22nd 2024

Patients With Intellectual Disabilities Face Distinct Challenges in COPD, Asthma Care

Brooke McCormick
Patients with intellectual disabilities experience inconsistent chronic obstructive pulmonary disease (COPD) consultations and higher rates of antibiotic prescriptions for asthma, highlighting the need for improved and tailored primary care management.
Hospital room | Image Credit: catinsyrup - stock.adobe.com
July 18th 2024

COPD Linked to Increased Mortality, Hospitalization Risk in Patients With HFpEF

Brooke McCormick
Chronic obstructive pulmonary disease (COPD) significantly heightens the risk of mortality and hospitalization in patients with heart failure with preserved ejection fraction (HFpEF).
Cityscape | Image Credit: leungchopan - stock.adobe.com
July 12th 2024

Study Finds Lower COPD Risk Among Patients Living in Cities With Fewer Than 50,000 Residents

Brooke McCormick
A Danish study found that living in cities with fewer than 50,000 residents and in newer, owned, and less dense homes is associated with a lower risk of developing chronic obstructive pulmonary disease (COPD).
what we're reading logo
July 2nd 2024

What We’re Reading: Shrinking Drug Coverage; Geriatric Care Training Investment; Escalated Patent Fight

AJMC Staff
Insurers continue to raise consumer costs despite covering fewer drugs and having more drug coverage restrictions; the Biden Administration is investing hundreds of millions of dollars to train geriatricians; the Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after the company refused to take down patents for its asthma and chronic obstructive pulmonary disease inhalers.
AJMC with Dr Munaf Siyamwala | Background image credit: ipopba - stock.adobe.com
July 1st 2024

131 Million Americans Live in Areas With Dangerous Air Pollution Levels, Report Finds

Brooke McCormick
Based on the 2024 State of the Air report, Munaf Siyamwala, MD, of Centerpoint Medical Center, noted that patients with COPD need personalized action plans to manage flare-ups exacerbated by poor air quality and extreme weather conditions.
AJMC with Dr Munaf Siyamwala | Background image credit: ipopba - stock.adobe.com
June 29th 2024

Heatwaves and High Pollution: Dr Munaf Siyamwala on Challenges Patients With COPD Face During Summertime

Brooke McCormick
Munaf Siyamwala, MD, of Centerpoint Medical Center, explained that summertime heatwaves and increased pollution significantly exacerbate symptoms for patients with chronic obstructive pulmonary disease (COPD).
FDA approval | Image Credit: Olivier Le Moal - stock.adobe.com
June 26th 2024

FDA Approves Ensifentrine for Maintenance Treatment of Adult Patients With COPD

Brooke McCormick
Today, the FDA approved ensifentrine (Ohtuvayre; Verona Pharma) for the maintenance treatment of moderate to severe chronic obstructive pulmonary disease (COPD) based on the successful phase 3 ENHANCE trials.
Female patient using inhaler | Image Credit: DALU11 - stock.adobe.com
June 12th 2024

High Rates of Inhaler Misuse Found Among Patients With COPD Using Soft Mist Inhalers

Brooke McCormick
Misuse of soft mist inhalers (SMIs) is common among patients with chronic obstructive pulmonary disease (COPD), particularly those with low education levels, higher symptom scores, and a shorter disease duration.
COPD cartoon | Image credit: peterschreiber.media - stock.adobe.com
May 23rd 2024

Dupilumab Improves Pre-, Postbronchodilator Lung Function Measures in Patients With COPD, Type 2 Inflammation

Brooke McCormick
Two abstracts presented at the American Thoracic Society 2024 International Conference analyzed the phase 3 LIBERTY COPD BOREAS trial, finding that dupilumab improves pre- and post-bronchodilator lung function measures in patients with chronic obstructive pulmonary disease (COPD) and type 2 (T2) inflammation.
Doctor holding lung animation | Image Credit: mi_viri - stock.adobe.com
May 20th 2024

Patients With COPD, PRISm at Increased All-Cause, Cause-Specific Mortality Risk

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and/or preserved ratio impaired spirometry (PRISm) have an increased risk of all-cause and cause-specific mortality, highlighting the need for better understanding of these conditions through increased spirometry data collection.
Heart animation | Image Credit: Siarhei - stock.adobe.com
May 16th 2024

Study: Italian Patients With COPD at High Risk of Severe Cardiovascular Events

Brooke McCormick
Italian patients with chronic obstructive pulmonary disease (COPD) face a significantly increased risk of severe cardiovascular events.
COPD drawing | Image Credit: Ivelin Radkov - stock.adobe.com
May 7th 2024

Low COPD Diagnosis Rate Among Japanese Patients Indicates Underdiagnosis

Brooke McCormick
There is an extremely low rate of chronic obstructive pulmonary disease (COPD) diagnoses in Japan, particularly among patients with airflow obstruction, despite regular respiratory function tests.
drawing of patient with anxiety | Image Credit: tadamichi - stock.adobe.com
May 2nd 2024

Study: Anxiety May Increase Acute Exacerbation Risk for Older Patients With COPD

Brooke McCormick
Older patients with chronic obstructive pulmonary disease (COPD) and anxiety exhibited exacerbated symptoms, increased comorbidities, and frequent acute exacerbations of COPD (AECOPD), emphasizing the need for routine psychiatric screening in COPD management.
Vitamin D | Image Credit: Katsiaryna Hatsak - stock.adobe.com
April 26th 2024

Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD

Brooke McCormick
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
COPD | Image Credit: peterschreiber.media - stock.adobe.com
April 24th 2024

Patients With COPD, Muscle Loss Phenotype Face Increased Risk of All-Cause, COPD-Related Death

Brooke McCormick
Patients with chronic obstructive pulmonary disease (COPD) and muscle loss phenotype (MLP) have an elevated risk of all-cause or COPD-related mortality.
COPD exacerbation | Image Credit: RFBSIP - stock.adobe.com
April 22nd 2024

Patient-Reported Outcomes Help to Uncover Frailty Patterns in Those With Acute COPD Exacerbations

Brooke McCormick
Study findings demonstrate the pivotal role of patient-reported outcomes in identifying frailty among individuals experiencing acute exacerbations of chronic obstructive pulmonary disease (COPD).
Jhon Vargas | Image provided by author
April 15th 2024

Contributor: Profit Over People—Medicare Advantage Plans Are Denying Vital NIV Therapy Coverage

Jhon Vargas
A longtime respiratory therapist calls for reform of Medicare Advantage in light of denials of coverage for patients who need non-invasive ventilation.
BMI formula written on notepad | Image Credit: Vitalii Vodolazskyi - stock.adobe.com
April 10th 2024

Study: Decreased BMI Increases Severe Exacerbation, All-Cause Mortality Risk in Patients With COPD

Brooke McCormick
Decreased body mass index (BMI) in patients with chronic obstructive pulmonary disease (COPD) was linked to a higher risk of severe exacerbations and all-cause mortality, emphasizing the importance of monitoring BMI for managing COPD and predicting outcomes.
Inhaler | Image Credit: Andrzej Tokarski - stock.adobe.com
April 3rd 2024

Study: 1 in 6 US Patients With COPD Suffers From Cost-Related Medication Nonadherence

Brooke McCormick
Medication nonadherence among patients with chronic obstructive pulmonary disease (COPD) is associated with increasing COPD symptoms, hospitalizations, morbidity, mortality, and health care expenditures.
12345678
...
25>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo